Financials
- Market Capitalization 16.57 M
- Employee 5
- Founded 2004
- CEO N/A
- Website www.akaritx.com
- Headquarter United Kingdom
- FIGI BBG003PMV495
- Industry 生物工学
総売上高
当期純利益
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
—
売上高対価格比率
-6 348.39
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4504 | NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.36 USD | +0.30% | -2.61% | -10.64% | -80.58% | 18.18 M USD | ||
| 4510 | ESLA Estrella Immunopharma, Inc. - Common Stock | 0.32 USD | -21.95% | -28.89% | -56.16% | -75.94% | 13.92 M USD | ||
| 4532 | MRKR Marker Therapeutics, Inc. - Common Stock | 1.01 USD | +4.12% | -6.48% | -12.93% | -0.98% | 16.84 M USD | ||
| 4537 | DYAI Dyadic International, Inc. - Common Stock | 0.45 USD | +2.27% | 0.00% | -6.25% | -57.55% | 16.40 M USD |